Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( October )
A postcard from ... Slovakia
We take a look at how this young country is managing healthcare and controlling costs(more)
The Pharmafocus Interview: Jan Lundberg
AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence
Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
PharmafocusNews Register for New Alert
News for February 2004
Previous Months: September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Cystic fibrosis inhaler to gain European approvals
Approval expected in a few months..(more)

 Persistence pays off as Erbitux finally wins approval
EU approval expected mid-2004..(more)

 Amersham optimistic before takeover despite profits
Weak dollar and restructuring take their toll..(more)

 Fast track surgery supplier chosen
Private companies chosen to tackle waiting lists..(more)

 Seretide could follow Seroxat in UK patent battle
GSK face double patent loss..(more)

 Generics continue to torment GlaxoSmithKline
Earnings to be flat until 2005..(more)

 It's good to talk, says Europe's ambitious regulator
EMEA aims to be world-class..(more)

 Buoyant Novartis continues to eye Roche
Novartis near takeover level..(more)

 Government signals shift away from NHS targets
Focus shifts to quality of care..(more)

 Trusts fail to meet consultant deadline
BMA blames DoH and trusts..(more)

 Escape routes diminishing for Aventis
Sanofi eyes Aventis US salesforce..(more)

 AZ switches Symbicort agency
Newcomer wins account..(more)

 Strong Roche says no to mergers
Roche posts strong growth figures..(more)

 War of words over atypicals link to diabetes
Companies try and limit link impact..(more)

 Vital funding for GP contract found
Health Minister relents to fund pleas..(more)

 Vernalis reassures investors on restructuring
Company streamlines drug pipeline..(more)

 Zeltia to press ahead with rejected cancer drug
Setback spurs Zeltia to revise plans..(more)

 AstraZeneca emerges unscathed from $2.6 billion patent loss
New product sales strengthen position..(more)

 Industry chair for communications body
New chair promises growth..(more)

 Sanofi makes takeover bid for 'weakened' Aventis
Aventis to fight E47 billion hostile bid..(more)

 Cambridge abandons neuroscience centre plans
Animal right's pressure forces rethink..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.